248 related articles for article (PubMed ID: 1713611)
21. Different signals mediate transforming growth factor-beta 1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells.
Franzén P; Ichijo H; Miyazono K
Exp Cell Res; 1993 Jul; 207(1):1-7. PubMed ID: 7686495
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of H-ras oncogene induces resistance to the growth-inhibitory action of transforming growth factor beta-1 (TGF-beta 1) and alters the number and type of TGF-beta 1 receptors in rat intestinal epithelial cell clones.
Filmus J; Zhao J; Buick RN
Oncogene; 1992 Mar; 7(3):521-6. PubMed ID: 1312703
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effects of transforming growth factor beta 1 on mitogenic response, transforming growth factor alpha, and c-myc in quiescent, well-differentiated colon carcinoma cells.
Mulder KM; Zhong Q; Choi HG; Humphrey LE; Brattain MG
Cancer Res; 1990 Dec; 50(23):7581-6. PubMed ID: 1701348
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
Guo Y; Kyprianou N
Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
[TBL] [Abstract][Full Text] [Related]
25. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
Kasid A; Bell GI; Director EP
J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
[TBL] [Abstract][Full Text] [Related]
26. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
[TBL] [Abstract][Full Text] [Related]
27. Relationship between actions of transforming growth factor (TGF)-beta and cell surface expression of its receptors in clonal osteoblastic cells.
Takeuchi Y; Fukumoto S; Matsumoto T
J Cell Physiol; 1995 Mar; 162(3):315-21. PubMed ID: 7860639
[TBL] [Abstract][Full Text] [Related]
28. Immortalization of EBV-infected B cells is not influenced by exogenous signals acting on B cell proliferation. Effects of mutant EL-4 thymoma cells and transforming growth factor-beta.
Straub C; Zubler RH
J Immunol; 1989 Jan; 142(1):87-93. PubMed ID: 2535862
[TBL] [Abstract][Full Text] [Related]
29. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
[TBL] [Abstract][Full Text] [Related]
30. Effect of transforming growth factor-beta1 on the cell growth and Epstein-Barr virus reactivation in EBV-infected epithelial cell lines.
Fukuda M; Ikuta K; Yanagihara K; Tajima M; Kuratsune H; Kurata T; Sairenji T
Virology; 2001 Sep; 288(1):109-18. PubMed ID: 11543663
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor beta isoform-specific differences in interactions with type I and II transforming growth factor beta receptors.
Zhou GH; Sechrist GL; Periyasamy S; Brattain MG; Mulder KM
Cancer Res; 1995 May; 55(10):2056-62. PubMed ID: 7743502
[TBL] [Abstract][Full Text] [Related]
32. Sensitivity to transforming growth factor beta 1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC down-regulation and p21waf1 induction are important early events.
Malliri A; Yeudall WA; Nikolic M; Crouch DH; Parkinson EK; Ozanne B
Cell Growth Differ; 1996 Oct; 7(10):1291-304. PubMed ID: 8891333
[TBL] [Abstract][Full Text] [Related]
33. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells.
Edmiston JS; Yeudall WA; Chung TD; Lebman DA
Cancer Res; 2005 Jun; 65(11):4782-8. PubMed ID: 15930298
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
[TBL] [Abstract][Full Text] [Related]
35. Characterization of B cell growth in systemic lupus erythematosus. Effects of recombinant 12-kDa B cell growth factor, interleukin 4 and transforming growth factor-beta.
Flescher E; Fossum D; Ballester A; Maizel A; Sharma S; Talal N
Eur J Immunol; 1990 Nov; 20(11):2425-30. PubMed ID: 2253682
[TBL] [Abstract][Full Text] [Related]
36. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells.
Kim IY; Ahn HJ; Zelner DJ; Shaw JW; Sensibar JA; Kim JH; Kato M; Lee C
Cancer Res; 1996 Jan; 56(1):44-8. PubMed ID: 8548772
[TBL] [Abstract][Full Text] [Related]
37. Loss of transforming growth factor-beta (TGF-beta) receptor type I mediates TGF-beta resistance in human papillomavirus type 16-transformed human keratinocytes at late stages of in vitro progression.
Mi Y; Borger DR; Fernandes PR; Pirisi L; Creek KE
Virology; 2000 May; 270(2):408-16. PubMed ID: 10793000
[TBL] [Abstract][Full Text] [Related]
38. Effects of recombinant human transforming growth factor-beta 1 or/and interleukin-6 on growth inhibition and proto-oncogene c-myc expression in human leukemia cells.
Feng R; Shen S; Hui H; Jin M
Chin Med J (Engl); 1997 Nov; 110(11):847-50. PubMed ID: 9772416
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor beta 1 selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed fibrosarcoma cell lines.
Hurta RA; Greenberg AH; Wright JA
J Cell Physiol; 1993 Aug; 156(2):272-9. PubMed ID: 8344985
[TBL] [Abstract][Full Text] [Related]
40. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
Tseng CT; Springgate CF; Piela TH; Choi YS
J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
